Entrada Therapeutics, Inc.

At Entrada Therapeutics, we are pioneering a new era in medicine by focusing on intracellular therapeutics. Our mission is driven by a profound commitment to transform the lives of patients afflicted by devastating diseases. Through innovative science and our proprietary Endosomal Escape Vehicle (EEV™) Platform, we aim to engage difficult-to-reach cellular targets that have long been deemed undruggable. Our cutting-edge approach allows for the effective intracellular delivery of RNA, antibodies, and other therapeutics, addressing significant unmet medical needs.

We are devoted to advancing a robust pipeline that spans multiple therapeutic areas, including neuromuscular diseases, ocular conditions, immunology, and metabolic disorders. Our current focus includes several programs targeting Duchenne Muscular Dystrophy, utilizing advanced oligonucleotide technologies to promote exon skipping and ultimately restore protein function in affected patients. The versatility and modularity of our EEV™ Platform enable us to rapidly adapt to various therapeutic modalities, thereby accelerating the path from discovery to clinical development. Becoming an Entradan means being part of a passionate team committed to scientific excellence, innovation, and compassion towards the patient community.